These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23748470)

  • 1. Cathepsin L inhibition by the small molecule KGP94 suppresses tumor microenvironment enhanced metastasis associated cell functions of prostate and breast cancer cells.
    Sudhan DR; Siemann DW
    Clin Exp Metastasis; 2013 Oct; 30(7):891-902. PubMed ID: 23748470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin L inactivation leads to multimodal inhibition of prostate cancer cell dissemination in a preclinical bone metastasis model.
    Sudhan DR; Pampo C; Rice L; Siemann DW
    Int J Cancer; 2016 Jun; 138(11):2665-77. PubMed ID: 26757413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin L in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor KGP94.
    Sudhan DR; Rabaglino MB; Wood CE; Siemann DW
    Clin Exp Metastasis; 2016 Jun; 33(5):461-73. PubMed ID: 27055649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of a water-soluble phosphate prodrug salt and structural analogues of KGP94, a lead inhibitor of cathepsin L.
    Parker EN; Odutola SO; Wang Y; Strecker TE; Mukherjee R; Shi Z; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1304-1310. PubMed ID: 28117205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient and concise synthesis of a selective small molecule non-peptide inhibitor of cathepsin L: KGP94.
    Munikishore R; Wang LL; Zhang S; Zhao QS; Zuo Z
    Bioorg Chem; 2021 Nov; 116():105317. PubMed ID: 34488126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial evaluation of the antitumour activity of KGP94, a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin L.
    Chavarria GE; Horsman MR; Arispe WM; Kumar GD; Chen SE; Strecker TE; Parker EN; Chaplin DJ; Pinney KG; Trawick ML
    Eur J Med Chem; 2012 Dec; 58():568-72. PubMed ID: 23168380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression.
    Tholen M; Wolanski J; Stolze B; Chiabudini M; Gajda M; Bronsert P; Stickeler E; Rospert S; Reinheckel T
    J Biol Chem; 2015 Jun; 290(25):15758-15769. PubMed ID: 25957406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin L is involved in proliferation and invasion of breast cancer cells.
    Qin G; Cai Y; Long J; Zeng H; Xu W; Li Y; Liu M; Zhang H; He ZL; Chen WG
    Neoplasma; 2016; 63(1):30-6. PubMed ID: 26639231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin L targeting in cancer treatment.
    Sudhan DR; Siemann DW
    Pharmacol Ther; 2015 Nov; 155():105-16. PubMed ID: 26299995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion.
    Sankpal NV; Brown TC; Fleming TP; Herndon JM; Amaravati AA; Loynd AN; Gillanders WE
    BMC Cancer; 2021 May; 21(1):541. PubMed ID: 33980181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cysteine cathepsin L is a marker of invasion and metastasis in ovarian cancer.
    Zhang W; Wang S; Wang Q; Yang Z; Pan Z; Li L
    Oncol Rep; 2014 Mar; 31(3):1334-42. PubMed ID: 24402045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.
    Mao Z; Sang MM; Chen C; Zhu WT; Gong YS; Pei DS
    Int J Biol Sci; 2019; 15(6):1310-1324. PubMed ID: 31223289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between cathepsin L and invasion and metastasis of ovarian carcinoma cells].
    Wang SM; Li L; Zhang W; Li DR; Tang BJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):598-602. PubMed ID: 21029616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel cathepsin inhibitors with potent anti-metastatic effects in breast cancer cells.
    Yuan L; Sheng L; He W; Zou C; Hu B; Liu J; Ge W; Liu Y; Wang J; Ma E
    Bioorg Chem; 2018 Dec; 81():672-680. PubMed ID: 30253340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin L promotes ionizing radiation-induced U251 glioma cell migration and invasion through regulating the GSK-3β/CUX1 pathway.
    Fei Y; Xiong Y; Shen X; Zhao Y; Zhu Y; Wang L; Liang Z
    Cell Signal; 2018 Apr; 44():62-71. PubMed ID: 29331585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma.
    Niedergethmann M; Wostbrock B; Sturm JW; Willeke F; Post S; Hildenbrand R
    Pancreas; 2004 Oct; 29(3):204-11. PubMed ID: 15367886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin L is involved in X-ray-induced invasion and migration of human glioma U251 cells.
    Xiong Y; Ji W; Fei Y; Zhao Y; Wang L; Wang W; Han M; Tan C; Fei X; Huang Q; Liang Z
    Cell Signal; 2017 Jan; 29():181-191. PubMed ID: 27989700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
    Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
    Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.